Previous 10 | Next 10 |
Comparing IRadimed To Another Monopoly IRadimed ( IRMD ) is the only provider of non-magnetic MRI products. Revenue and earnings have been growing robustly. The company is on course to its fourth consecutive quarter of record revenue and improving margins, yet the stock price performance o...
On the surface, Zynex’s (NASDAQ: ZYXI ) model of selling electrical stimulation devices and supplies at high margins with technically little direct competition appears to be an attractive opportunity. However, the company’s revenues reveal a business model increasingly vulnera...
ENGLEWOOD, Colo. , Oct. 17, 2019 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagno...
This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. Winning Bounc...
We bought the medical device company Zynex ( ZYXI ) for the SHU portfolio twice (in June, at $10.36 and $8.75 ) and we had great expectations for the stock that didn't pan out, at least not immediately: As you can see, at the end of June the stock sort of crashed, not because of any bad...
This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. Winning Bounc...
Wall Street went through a minor panic attack on Wednesday, with investors sending major indexes down roughly 2% to add to Tuesday's losses. Some more poor economic data signaled that the U.S. economy might finally be faltering after a long bull run, and that has market participants trying to an...
Zynex ( ZYXI +11.5% ) surges to its highest since June on heavy volume following news that it achieved Q3 order growth of 95% Y/Y and 30% Q/Q, on top of Q2's 65% Y/Y jump in orders. More news on: Zynex, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Gainers : The Stars Group (NASDAQ: TSG ) +29% . Naked Brand Group (NASDAQ: NAKD ) +15% . Yuma Energy (NYSEMKT: YUMA ) +15% . Surface Oncology (NASDAQ: SURF ) +14% . Catalyst Biosciences (NASDAQ: CBIO ) +13% . NIO (NYSE: NIO ) +13% . Zynex (NASDAQ: ZYXI ) +11% . Aimmune Therapeutics ...
ENGLEWOOD, Colo. , Oct. 2, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, tod...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) rose 22.6% to $0.0461 on volume of 144,150,002 shares Vintage Wine Estates Inc. (VWE) rose 21.5% to $0.0849 on volume of 35,620,484 shares NVIDIA Corporation (NVDA) rose 2.4% to $115.03 on volume of 35,381,...
Zynex Reports Second Quarter 2024 Financial Results PR Newswire Q2 2024 Revenue Increased 11% to $49.9 Million ENGLEWOOD, Colo. , July 25, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the ma...
Zynex Sets Second Quarter 2024 Earnings Call PR Newswire ENGLEWOOD, Colo. , July 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain manage...